16:40 EST REGENXBIO (RGNX) trading resumes
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RGNX:
- Regenxbio says FDA issues CRL regarding BLA for RGX-121
- REGENXBIO trading halted, news pending
- RegenXBio: Clinical Hold on RGX-111/121 Seen as Manageable Timing Issue, Core Gene Therapy Platform and Key Value Drivers Remain Intact Supporting Buy Rating
- Stifel says Regenxbio’s RGX-121 delay not unexpected, not difficult to resolve
- Midday Fly By: AT&T reports Q4 beat, Amazon cuts 16,000 jobs